Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|August 23, 2012
Individualization of tamoxifen treatment for breast carcinomaL Binkhorst, T van Gelder, R H J Mathijssen
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Limited potential of hepatic arterial infusion of irinotecanF A De Jong, R H J Mathijssen, J Verweij
British Journal of Cancer|July 14, 2017
Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlationsS Hu, R H J Mathijssen, P de Bruijn, et al.
British Journal of Cancer|January 9, 2014
Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlationsS Hu, R H J Mathijssen, P de Bruijn, et al.
British Journal of Cancer|July 11, 2002
Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38R H J Mathijssen, J Verweij, W J Loos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2019
Novel treatment options in the management of metastatic castration-naïve prostate cancer; which treatment modality to choose?B P S Belderbos, R de Wit, M P J Lolkema, et al.
British Journal of Cancer|April 12, 2017
Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancerA Janssen, C P M Verkleij, A van der Vlist, et al.
British Journal of Cancer|January 22, 2004
Factors affecting pharmacokinetic variability of oral topotecan: a population analysisF Léger, W J Loos, J Fourcade, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2006
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumorsA Felici, W J Loos, J Verweij, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 31, 2018
A new method for the determination of total and released docetaxel from docetaxel-entrapped core-crosslinked polymeric micelles (CriPec®) by LC-MS/MS and its clinical application in plasma and tissues in patients with various tumoursC L Braal, P de Bruijn, F Atrafi, et al.
Pageof 5